DR WENDALLA (Belgium). I would like to ask you did you notice some changes in bladder capacity when you administered alpha-adrenolytic drugs in upper motor neurone bladders? DR HACHEN. Yes indeed. There was a very slight increase as I showed it in my slide but it was not statistically significant.
DR MADERSBACHER (Austria). I think it was Mr Edwards who could show in animal
experiments that under phenoxybenzamine the rehabilitation prospects in the animal experiments was quicker, so he thought that spinal shock had something to do with the over activation of the sympathetic system. Did you see in your patients any change in their rehabilitation in the sense that reflex function recovered earlier than in other groups or have you any comparison or any experience ? DR HACHEN. I am afraid we have not looked into this parameter with any detail and I have no fact that is available for that. It doesn't seem to me that there has been any change for instance regarding reflex activity coming out after spinal shock. I don't think so, we usually started only after 3 to 4 months after the lesion. DR MADERSBACHER. You did not try it in the early stages ? DR HACHEN. We never tried phenoxybenzamine in the very early stages. DR MADERSBACHER. Maybe it would be worth while testing this. You mentioned that in normal people that Dibenzyline would cause retrograde ejaculation. They have no emission at all, because the transport of the semen is inhibited. They have no retrograde ejaculation because they have no emission at all. DR HACHEN. Thank you for those comments. I might add that in most of these cases we performed an IV Phentolamine test before starting phenoxybenzamine. There is quite a good correlation between this test and the results that can be obtained with prolonged oral administration of phenoxybenzamine. If one notices a funnel-shaped opening of the bladder neck and proximal urethra within 10 minutes after the intravenous injection of 15 mgms phentolamine the chances are good that prolonged oral treatment with an alpha-adrenolytic drug will also yield positive results. DR PERKASH (U.S.A.). Had you to increase the dose of Dibenzyline in your patients when you were successful had you increased the doses during the time ?
DR HACHEN. No, we usually started with 10 mgms twice a day and we stayed on 40 mgms. We noticed that the dose range between efficacy and tolerance was around 40 to 50. If you increase over 40 to 50 you get into several problems, especially of tiredness due to oversedation. The patients feel extremely exhausted and there is a significant tendency to hypotension. Up to 40 we had no side effects but I had a few patients whom I have treated, non paraplegics whom I have treated for similar problems, for instance diabetic patients with neurogenic bladder dysfunction. Frequently they seem to be more sensitive to phenoxybenzamine than patients in a wheel chair. DR PERKASH (U.S.A.). I have very little experience of that. I only would like to mention patients who may be sensitive even to 10 mgms.
One of the things is that Dibenzyline is irritant to the stomach and you must tell the patients to take it after eating. A lot of patients I found it wise to start with 10 mgms twice a day and after 2 weeks you may just reduce to 10 mgms a day. In the night after meals they have less problems with feeling lightheaded in the morning. I have got several patients whom I've kept now for almost 3 or 4 years on a small dose and they function very well and that's also been proved by doing urodynamics on them.
MR GIBBON (G.B.). I am rather surprised to hear the side effects being almost ignored in this way. We do have problems with side effects and the most serious one that PARAPLEGIA I have found has been nasal congestion to the point at which the patient can't breathe freely, and they give up taking their tablets. Now is this not something that you have come across ? DR HACHEN. It has never been mentioned by my patients. You have tablets you say, we have capsules. Maybe the galenic form different. I don't know whether you have slower release or a different tablet than we have but at least with our 4 x 10 mgm capsules we have never had any nasal congestion problems.
MR GIBBON.
Well this is what we use, phenoxybenzamine 10 mgms three times a day usually; and the patients complain that they can't breathe and they stop taking their tablets so there must be some difference somewhere.
DR HACHEN. Among the urological side effects one occasionally encounters a pseudo "stress incontinence" in patients with caude equinae lesions and decreased outflow sensation in patients with incomplete lesions. DR GEISLER (Canada). Gentlemen, can you give some ground rules to those in the audience who may not have the sophistication of a urodynamic laboratory, so they know when they might use these drugs, or do you suggest that these drugs should not be used unless there are sophisticated urodynamic studies done first ? DR HACHEN. Well there are three substances which can be used as test substances during the urodynamic investigation: the first one is Urecholine and we all realise that Urecholine must be dealt with very carefully as long as we are not sure that we have no infravesical functional or organic obstruction. It might therefore lead to reflux formation, but I think we are justified to use an injection of half an ampule, that is 5 to 10 mgms of Urecholine subcutaneously to see whether we have any reflex activity of the detrusor muscle to get the diagnosis of an upper motor neurone lesion. We may continue either by giving the patient oral Urecholine or a cholinesterase inhibitor like distigmine bromide. The second substance we use as a test substance is Lioresal. Lioresal can be given intra venously. It has to be given at a dosage of about 20 mgms intravenously. If within 15 minutes after injection you see in the urethral pressure profile a significant decrease of the maximal resistance and concomitantly lowering of the residual volume you may assume that the urethral sphincter spasticity was a major direct cause of retention and that sphincterotomy is an indication rather than bladder neck resection. The third substance used is Regitine in order to determine the category of patients that may benefit from alpha-adrenolytic treatment. This is just a very schematic approach but there are 3 substances which we can combine eventually with dynamic evaluations and which give us quite clear indication of whether or not medication is justified or not. I think the question was whether without the urodynamics one can use these drugs. I think that you could because you have clinical evidence when you are doing intermittent catheterisation. You can find that if you put a patient on phenoxybenzamine 10 mgms twice a day or 10 mgms
